Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies ; volume:18 ; number:1 ; day:12 ; month:2 ; year:2024 ; pages:1-20 ; date:12.2024
BMC chemistry ; 18, Heft 1 (12.2.2024), 1-20, 12.2024

Creator: Fouad, Marwa A.
Osman, Alaa A.
Abdelhamid, Noha M.
Rashad, Mai W.
Nabawy, Ashrakat Y.
El Kerdawy, Ahmed M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13065-024-01130-5

URN: urn:nbn:de:101:1-2404220824420.963873728323

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fouad, Marwa A.
Osman, Alaa A.
Abdelhamid, Noha M.
Rashad, Mai W.
Nabawy, Ashrakat Y.
El Kerdawy, Ahmed M.
SpringerLink (Online service)

Other Objects (12)

Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore

Tautomerism in structure-based 3D pharmacophore modeling

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

Glide XP fragment docking and structurebased pharmacophores

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies

Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore

Tautomerism in structure-based 3D pharmacophore modeling

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

Glide XP fragment docking and structurebased pharmacophores

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies

Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore

Tautomerism in structure-based 3D pharmacophore modeling

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

Glide XP fragment docking and structurebased pharmacophores

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore

Tautomerism in structure-based 3D pharmacophore modeling

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

Glide XP fragment docking and structurebased pharmacophores

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies

Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore

Tautomerism in structure-based 3D pharmacophore modeling

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

Glide XP fragment docking and structurebased pharmacophores

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies

Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore

Tautomerism in structure-based 3D pharmacophore modeling

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

Glide XP fragment docking and structurebased pharmacophores

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay

Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures

Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies

Related objects

Reset password